Lloyds Bank PLC
LONDON, March 12, 2021 (GLOBE NEWSWIRE) -- Lloyds Bank plc announces that on 11 March 2021 it filed its Annual Report on Form 20-F for the year ended 31 December 2020 with the Securities and Exchange Commission.
A copy of the Form 20-F is available through the 'Investors' section of our website at www.lloydsbankinggroup.com and also online at www.sec.gov
Shareholders can receive hard copies of the complete audited financial statements free of charge upon request. Printed copies of the 2020 Lloyds Bank plc Annual Report on Form 20-F can be requested from Investor Relations by email to investor.relations@lloydsbanking.com
For further information:
| Investor Relations | |
| Douglas Radcliffe | +44 (0)20 7356 1571 |
| Group Investor Relations Director | |
| douglas.radcliffe@lloydsbanking.com | |
| Corporate Affairs | |
| Matt Smith | +44 (0)20 7356 3522 |
| Head of Media Relations | |
| matt.smith@lloydsbanking.com | |
Click on, or paste the following link into your web browser, to view the associated PDF document.
http://www.rns-pdf.londonstockexchange.com/rns/1683S_1-2021-3-12.pdf
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ALK Abello19.12.2025 22:46:46 CET | Press release
Major shareholder announcement
ALK Abello19.12.2025 22:46:46 CET | Pressemeddelelse
Storaktionærmeddelelse
Zealand Pharma19.12.2025 22:00:00 CET | Press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Boehringer Ingelheim Limited19.12.2025 21:10:00 CET | Press release
U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
Novartis Pharma AG19.12.2025 20:30:06 CET | Press release
Novartis and US government reach agreement on lowering drug prices in the US
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
